Ovid Therapeutics Inc. · NASDAQ:OVID

Friedman Bart received 8,789 Ovid Therapeutics Inc. shares as an award (Form 4)

Traded Apr 7, 2026 · Filed Apr 9, 2026

On Apr 7, 2026, Friedman Bart (Director) received 8,789 Ovid Therapeutics Inc. shares as an award at US$2.56 for US$22,500, leaving 8,789 shares. Filed Apr 9, 2026 (Form 4).

Awarded
8,789 shares
Price
US$2.56
Value
US$22,500
Holding after
8,789 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 7, 2026Common StockAward8,789US$2.568,789Direct

Source

View original at SEC

Related